Bezdek Trevor 4

What Happened

• Trevor Bezdek, a director of GoodRx Holdings, was granted 110,294 restricted stock units (RSUs) on June 8, 2026. The award is reported as an acquisition at $0.00 (code A), meaning these are compensation RSUs rather than a cash purchase; the filing shows no immediate cash value. The RSUs represent a contingent right to one share of Class A common stock each and will vest 100% on December 31, 2027, subject to continued service.

Key Details

• Transaction date: 2026-06-08; filing date: 2026-06-10 (timely filing).
• Transaction type/code: Award/Grant (A); price reported $0.00.
• Amount: 110,294 restricted stock units (each converts to one share upon vesting).
• Vesting: 100% on December 31, 2027, subject to continued service (Footnote F1).
• Shares owned after transaction: Not specified in the provided summary of the filing.
• Additional footnotes (F2–F5): Several disclosures reference shares held in grantor retained annuity trusts (GRATs) where the reporting person or spouse serves as trustee/annuitant; some holdings are disclaimed as not beneficially owned.

Context

• RSU grants are a common form of executive/director compensation and vest over time; they do not represent an immediate market purchase or sale. This award will convert to shares only if vesting conditions are met, so it’s not the same signal as an open-market purchase. No indication of a 10b5-1 plan, sale, or tax-withholding sale was reported in the provided data.